查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386587

核酸檢測市場報告：2030 年趨勢、預測與競爭分析

Nucleic Acid Testing Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

核酸檢測趨勢與預測

預計到2030年，全球核酸檢測市場將達到67億美元，2024年至2030年年複合成長率為11.2%。該市場的主要驅動力是對準確和快速診斷測試的需求不斷成長，對血庫和輸血中心核酸檢測套組的需求不斷成長，以及癌症、遺傳疾病和感染疾病的增加。全球核酸檢測市場前景廣闊，醫院/診所、病理實驗室、學術/研究所市場蘊藏商機。

核酸檢測市場洞察

Lucintel 預測，由於大量使用核酸檢測套組進行基因分型和亞型分型以幫助確定病毒量，感染疾病將繼續成為最大的細分市場。

由於人口中感染疾病的盛行率不斷上升以及政府對核酸檢測研究和開發的大力支持，預計北美在預測期內將出現最高的成長。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2. 哪些細分市場最有前景且成長潛力最大？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球核酸檢測市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球核酸檢測市場趨勢（2018-2023）與預測（2024-2030）
  • 按產品類型分類的全球核酸檢測市場
    • 聚合酶鍊式反應
    • 連接酶鍊式反應
    • 轉錄媒介增幅
    • 全基因組序列測定
    • 其他
  • 按適應症分類的全球核酸檢測市場
    • 感染疾病
    • 癌症
    • 刑事鑑定
    • 個人化醫療
    • 其他
  • 按最終用途分類的全球核酸檢測市場
    • 醫院和診所
    • 病理研究所
    • 學術/研究機構
    • 其他

第4章 2018-2030年分地區市場趨勢及預測分析

  • 全球核酸檢測市場（按地區）
  • 北美核酸檢測市場
  • 歐洲核酸檢測市場
  • 亞太核酸檢測市場
  • 其他區域核酸檢測市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按產品類型分類的全球核酸檢測市場成長機會
    • 全球核酸檢測市場成長機會（按適應症）
    • 按最終用途分類的全球核酸檢測市場成長機會
    • 全球核酸檢測市場按地區成長機會
  • 全球核酸檢測市場新趨勢
  • 戰略分析
    • 新產品開發
    • 全球核酸檢測市場產能擴張
    • 全球核酸檢測市場的合併與收購
    • 認證和許可

第7章 主要企業概況

  • F. Hoffmann-La Roche
  • Becton and Dickinson
  • Danaher
  • Abbott Laboratories
  • Illumina
  • Siemens Healthineers
  • bioMerieux
簡介目錄

Nucleic Acid Testing Trends and Forecast

The future of the global nucleic acid testing market looks promising with opportunities in the hospital & clinic, pathology laboratory, and academic & research organization markets. The global nucleic acid testing market is expected to reach an estimated $6.7 billion by 2030 with a CAGR of 11.2% from 2024 to 2030. The major drivers for this market are rising need for precise and quick diagnostic tests, increasing need for nucleic acid test kits from blood banks and transfusion centers, and escalating incidence of cancer, genetic disorders, and infectious diseases.

A more than 150-page report is developed to help in your business decisions.

Nucleic Acid Testing by Segment

The study includes a forecast for the global nucleic acid testing by product type, indication, end use, and region.

Nucleic Acid Testing Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Polymerase Chain Reaction
  • Ligase Chain Reaction
  • Transcription-Mediated Amplification
  • Whole Genome Sequencing
  • Others

Nucleic Acid Testing Market by Indication [Shipment Analysis by Value from 2018 to 2030]:

  • Infectious Disease
  • Cancer
  • Forensic Testing
  • Personalized Medicine
  • Others

Nucleic Acid Testing Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals & Clinics
  • Pathology Laboratories
  • Academic & Research Organization
  • Others

Nucleic Acid Testing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Nucleic Acid Testing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies nucleic acid testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the nucleic acid testing companies profiled in this report include-

  • F. Hoffmann-La Roche
  • Becton and Dickinson
  • Danaher
  • Abbott Laboratories
  • Illumina
  • Siemens Healthineers
  • bioMerieux

Nucleic Acid Testing Market Insights

Lucintel forecasts that infectious disease will remain the largest segment due to considerable use of nucleic acid testing kit for genotype and subtype identification that aids in determining viral load.

North America is expected to witness highest growth over the forecast period due to increasing prevalence of infectious diseases among population and presence of strong government support for nucleic acid testing research and development in the region.

Features of the Global Nucleic Acid Testing Market

Market Size Estimates: Nucleic acid testing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Nucleic acid testing market size by product type, indication, end use, and region in terms of value ($B).

Regional Analysis: Nucleic acid testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, indications, end uses, and regions for the nucleic acid testing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the nucleic acid testing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the nucleic acid testing market size?

Answer: The global nucleic acid testing market is expected to reach an estimated $6.7 billion by 2030.

Q.2 What is the growth forecast for nucleic acid testing market?

Answer: The global nucleic acid testing market is expected to grow with a CAGR of 11.2% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the nucleic acid testing market?

Answer: The major drivers for this market are rising need for precise and quick diagnostic tests, increasing need for nucleic acid test kits from blood banks and transfusion centers, and escalating incidence of cancer, genetic disorders, and infectious diseases.

Q4. What are the major segments for nucleic acid testing market?

Answer: The future of the nucleic acid testing market looks promising with opportunities in the hospital & clinic, pathology laboratory, and academic & research organization markets.

Q5. Who are the key nucleic acid testing market companies?

Answer: Some of the key nucleic acid testing companies are as follows:

  • F. Hoffmann-La Roche
  • Becton and Dickinson
  • Danaher
  • Abbott Laboratories
  • Illumina
  • Siemens Healthineers
  • bioMerieux

Q6. Which nucleic acid testing market segment will be the largest in future?

Answer: Lucintel forecasts that infectious disease will remain the largest segment due to considerable use of nucleic acid testing kit for genotype and subtype identification that aids in determining viral load.

Q7. In nucleic acid testing market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to increasing prevalence of infectious diseases among population and presence of strong government support for nucleic acid testing research and development in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the nucleic acid testing market by product type (polymerase chain reaction, ligase chain reaction, transcription-mediated amplification, whole genome sequencing, and others), indication (infectious disease, cancer, forensic testing, personalized medicine, and others), end use (hospitals & clinics, pathology laboratories, academic & research organization, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Nucleic Acid Testing Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Nucleic Acid Testing Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Nucleic Acid Testing Market by Product Type
    • 3.3.1: Polymerase Chain Reaction
    • 3.3.2: Ligase Chain Reaction
    • 3.3.3: Transcription-mediated Amplification
    • 3.3.4: Whole Genome Sequencing
    • 3.3.5: Others
  • 3.4: Global Nucleic Acid Testing Market by Indication
    • 3.4.1: Infectious Disease
    • 3.4.2: Cancer
    • 3.4.3: Forensic Testing
    • 3.4.4: Personalized Medicine
    • 3.4.5: Others
  • 3.5: Global Nucleic Acid Testing Market by End Use
    • 3.5.1: Hospitals & Clinics
    • 3.5.2: Pathology Laboratories
    • 3.5.3: Academic & Research Organization
    • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Nucleic Acid Testing Market by Region
  • 4.2: North American Nucleic Acid Testing Market
    • 4.2.1: North American Nucleic Acid Testing Market by Indication: Infectious Disease, Cancer, Forensic Testing, Personalized Medicine, and Others
    • 4.2.2: North American Nucleic Acid Testing Market by End Use: Hospitals & Clinics, Pathology Laboratories, Academic & Research Organization, and Others
  • 4.3: European Nucleic Acid Testing Market
    • 4.3.1: European Nucleic Acid Testing Market by Indication: Infectious Disease, Cancer, Forensic Testing, Personalized Medicine, and Others
    • 4.3.2: European Nucleic Acid Testing Market by End Use: Hospitals & Clinics, Pathology Laboratories, Academic & Research Organization, and Others
  • 4.4: APAC Nucleic Acid Testing Market
    • 4.4.1: APAC Nucleic Acid Testing Market by Indication: Infectious Disease, Cancer, Forensic Testing, Personalized Medicine, and Others
    • 4.4.2: APAC Nucleic Acid Testing Market by End Use: Hospitals & Clinics, Pathology Laboratories, Academic & Research Organization, and Others
  • 4.5: ROW Nucleic Acid Testing Market
    • 4.5.1: ROW Nucleic Acid Testing Market by Indication: Infectious Disease, Cancer, Forensic Testing, Personalized Medicine, and Others
    • 4.5.2: ROW Nucleic Acid Testing Market by End Use: Hospitals & Clinics, Pathology Laboratories, Academic & Research Organization, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Nucleic Acid Testing Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Nucleic Acid Testing Market by Indication
    • 6.1.3: Growth Opportunities for the Global Nucleic Acid Testing Market by End Use
    • 6.1.4: Growth Opportunities for the Global Nucleic Acid Testing Market by Region
  • 6.2: Emerging Trends in the Global Nucleic Acid Testing Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Nucleic Acid Testing Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Nucleic Acid Testing Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: F. Hoffmann-La Roche
  • 7.2: Becton and Dickinson
  • 7.3: Danaher
  • 7.4: Abbott Laboratories
  • 7.5: Illumina
  • 7.6: Siemens Healthineers
  • 7.7: bioMerieux